30 Jun 2025
In fine chemical and pharmaceutical manufacturing, handling slurry-based reactions—such as condensations and hydrogenations—poses unique challenges. As companies look to optimize efficiency, safety, and scalability, the choice between batch and continuous flow processes becomes critical.
This blog explores the technical and operational trade-offs between these two approaches, especially when solids or catalysts are involved.
Slurry-phase reactions involve solid-liquid or gas-liquid-solid phases:
Both can be complex to scale due to issues in mixing, filtration, and safety.
According to the scale-up chart, batch systems can take 12–24 months from lab to commercial scale, while flow systems can be validated in 6–12 months. Continuous setups also allow:
Example: SlurryFLO reactors by AmarFLO are specifically built for such applications, with anti-settling design and compatibility for viscous and solid-laden flows.
Choose Batch When:
Choose Flow When:
Sometimes, the best choice is both. For instance, a hybrid approach might involve using a batch process for the initial condensation step, where complex reactants or variable raw materials are involved, followed by a continuous flow setup for subsequent hydrogenation or crystallization, where tighter control over reaction conditions and improved scalability offer significant advantages. This combination leverages the flexibility of batch operations and the efficiency and consistency of continuous processing.
Modern process development is no longer “either-or.” As strategically stated in industry guides, success lies in matching the process to the reaction complexity, safety profile, and business goals.
“Flexibility for future adaptations as technologies evolve is critical.” — Strategic Implementation
📧Contact us: [email protected] [email protected]